0001209191-21-039033.txt : 20210608 0001209191-21-039033.hdr.sgml : 20210608 20210608192015 ACCESSION NUMBER: 0001209191-21-039033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210604 FILED AS OF DATE: 20210608 DATE AS OF CHANGE: 20210608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEST MICHAEL D CENTRAL INDEX KEY: 0001202529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 211003542 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE, SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AgeX Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821436829 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-671-8370 MAIL ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-04 0 0001708599 AgeX Therapeutics, Inc. AGE 0001202529 WEST MICHAEL D 1101 MARINA VILLAGE PARKWAY, SUITE 201 ALAMEDA CA 94501 1 1 0 0 Chief Executive Officer Option to Purchase Common Stock 1.45 2021-06-04 4 A 0 120000 0.00 A 2031-06-03 Common Stock 120000 120000 D Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date. /s/Michael D. West 2021-06-08